163 related articles for article (PubMed ID: 10623703)
1. Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
Gandara DR; Vokes E; Green M; Bonomi P; Devore R; Comis R; Carbone D; Karp D; Belani C
J Clin Oncol; 2000 Jan; 18(1):131-5. PubMed ID: 10623703
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
Fossella FV; Lee JS; Shin DM; Calayag M; Huber M; Perez-Soler R; Murphy WK; Lippman S; Benner S; Glisson B
J Clin Oncol; 1995 Mar; 13(3):645-51. PubMed ID: 7884425
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Fossella FV; DeVore R; Kerr RN; Crawford J; Natale RR; Dunphy F; Kalman L; Miller V; Lee JS; Moore M; Gandara D; Karp D; Vokes E; Kris M; Kim Y; Gamza F; Hammershaimb L
J Clin Oncol; 2000 Jun; 18(12):2354-62. PubMed ID: 10856094
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel: a review of its use in non-small cell lung cancer.
Comer AM; Goa KL
Drugs Aging; 2000 Jul; 17(1):53-80. PubMed ID: 10933515
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.
Gandara DR; Edelman MJ; Lau D
Semin Oncol; 1999 Jun; 26(3 Suppl 10):3-7. PubMed ID: 10437743
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel for previously treated non-small-cell lung cancer.
Fossella FV
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):45-51. PubMed ID: 12108897
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
Shepherd FA; Dancey J; Ramlau R; Mattson K; Gralla R; O'Rourke M; Levitan N; Gressot L; Vincent M; Burkes R; Coughlin S; Kim Y; Berille J
J Clin Oncol; 2000 May; 18(10):2095-103. PubMed ID: 10811675
[TBL] [Abstract][Full Text] [Related]
9. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
Fossella FV; Lee JS; Berille J; Hong WK
Semin Oncol; 1995 Apr; 22(2 Suppl 4):22-9. PubMed ID: 7740327
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
Khuri FR
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.
Fossella FV
Semin Oncol; 1999 Oct; 26(5 Suppl 16):17-23; discussion 41-2. PubMed ID: 10585004
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme?
Armand JP
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():223-30. PubMed ID: 10895158
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience.
Latreille J; Gelmon KA; Hirsh V; Laberge F; Maksymiuk AW; Shepherd FA; Delorme F; Bérille J
Invest New Drugs; 1998-1999; 16(3):265-70. PubMed ID: 10360607
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.
Francis PA; Rigas JR; Kris MG; Pisters KM; Orazem JP; Woolley KJ; Heelan RT
J Clin Oncol; 1994 Jun; 12(6):1232-7. PubMed ID: 7911159
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of docetaxel in non-small cell lung cancer patients previously treated with platinum-containing chemotherapy. French Group of Pneumo-Cancerology].
Robinet G; Thomas P; Pérol M; Vergnenègre A; Lena H; Taytard A; Paillotin D; Bessa EH; Schuller-Lebeau MP
Rev Mal Respir; 2000 Feb; 17(1):83-9. PubMed ID: 10756559
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.
Kunitoh H; Watanabe K; Onoshi T; Furuse K; Niitani H; Taguchi T
J Clin Oncol; 1996 May; 14(5):1649-55. PubMed ID: 8622084
[TBL] [Abstract][Full Text] [Related]
17. Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer.
Le Chevalier T; Bérille J; Zalcberg JR; Millward MJ; Monnier A; Douillard JY; McKeage MJ; James R; Soulas F; Loret C; Bougon N; Bizzari JP
Semin Oncol; 1999 Jun; 26(3 Suppl 11):13-8. PubMed ID: 10458205
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.
Zalcberg J; Millward M; Bishop J; McKeage M; Zimet A; Toner G; Friedlander M; Barter C; Rischin D; Loret C; James R; Bougan N; Berille J
J Clin Oncol; 1998 May; 16(5):1948-53. PubMed ID: 9586914
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
Millward MJ; Zalcberg J; Bishop JF; Webster LK; Zimet A; Rischin D; Toner GC; Laird J; Cosolo W; Urch M; Bruno R; Loret C; James R; Blanc C
J Clin Oncol; 1997 Feb; 15(2):750-8. PubMed ID: 9053501
[TBL] [Abstract][Full Text] [Related]
20. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
Harper P
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]